Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

01 December 2007

IMPDH activity on day 6 after kidney transplantation is significantly related to the risk of acute rejection in MMF treated patients

F. Sombogaard, R.A.A. Mathot, P. Glander, W. Weimar, T. van Gelder

Ann Transplant 2008; 13(1): 41-42 :: ID: 880207

Abstract

Background: Mycophenolic acid - the active metabolite of MMF - inhibits the enzyme inosine monophosphate dehydrogenase (IMPDH). Monitoring IMPDH activity could be a target to optimize MMF therapy. In this study we investigated the relationship between IMPDH activity and risk of BPAR in renal transplant patients.
Material/Methods: 101 de novo renal transplant patients were prospectively monitored for pharmacokinetics and pharmacodynamics of MMF treatment. One blood sample was taken pre transplant and 6 samples on day 6 post transplantation. The enzyme activity of IMPDH in PBMCs was measured using a validated HPLC method. IMPDH activity and MPA exposure was calculated as the area under the activity/concentration-time curve (AUC[sub]act [/sub]and AUC[sub]MPA[/sub]) using a linear trapezoidal rule. All acute rejection episodes were biopsy proven according Banff classification.
Results: Samples for IMPDH activity measurement were available from 78 patients (age 19-76 years) on day 6 (range 3-11) post transplantation. In 17 of the patients a BPAR was documented within one year after transplantation. The AUC[sub]act[/sub] of patients with BPAR was significantly higher compared to non-BPAR patients (394±287 vs. 255±156 h*μmol/s/mol AMP, p=0.017). No significant correlation was found between IMPDH activity pre (48±27 vs. 54±41 h*μmol/s/mol AMP; p=0.97) and at single time points post transplantation compared to BPAR. The AUC[sub]MPA[/sub] was not significantly different for both groups (36.5±17.0 and 37.0±19.7 h*mg/L; p=0.95).
Conclusions: In the largest patient series to date, IMPDH activity, measured as AUC[sub]act[/sub] on day 6, is signifi cantly correlated with BPAR after renal transplantation. Monitoring IMPDH activity is a promising, novel biomarker to optimize MMF treatment in renal transplant patients.

Keywords: Mycophenolic Acid, IMPDH, Percutaneous transsplenic

Comments

In Press

06 May 2022 : Original article  

Phosphatidylethanol (PEth) for Monitoring Sobriety in Liver Transplant Candidates: Preliminary Results of D...

Ann Transplant In Press; DOI: 10.12659/AOT.936293  

Most Viewed Current Articles

26 Jan 2022 : Review article  

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models

DOI :10.12659/AOT.934924

Ann Transplant 2022; 27:e934924

29 Dec 2021 : Original article  

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

24 Jul 2020 : Review article  

Kidney Transplantation in the Times of COVID-19 – A Literature Review

DOI :10.12659/AOT.925755

Ann Transplant 2020; 25:e925755

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358